Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(dimethylamino)-1-((2-(3-methoxyphenyl)phenoxy)methyl)ethyl Hydrogensuccinate Hydrochloride
2. Mci 9042
3. Mci-9042
4. Mono-(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl)succinate Hydrochloride
1. 125926-17-2
2. Sarpogrelate [inn]
3. Sarpogrelate (inn)
4. 4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic Acid
5. 19p708e787
6. Unii-19p708e787
7. Ncgc00167489-01
8. Ncgc00167489-03
9. Schembl49197
10. Gtpl210
11. Chembl52939
12. Sarpogrelate [who-dd]
13. Dtxsid7048328
14. Chebi:135697
15. Bcp08179
16. Bdbm50093789
17. Stk631325
18. Akos005563803
19. Db12163
20. Ncgc00167489-02
21. 4-{[1-(dimethylamino)-3-{2-[2-(3-methoxyphenyl)ethyl]phenoxy}propan-2-yl]oxy}-4-oxobutanoic Acid
22. Hy-10563
23. Cs-0002654
24. Ft-0712621
25. Ls-187,118
26. D08508
27. Q44931
28. 159s512
29. L000858
30. Sr-01000883998
31. J-513134
32. Sr-01000883998-1
33. (+-)-2-(dimethylamino)-1-((o-(m-methoxyphenethyl)phenoxy)methyl)ethyl Hydrogen Succinate
34. (- )-2-(dimethylamino)-1-((o-(m-methoxyphenethyl)phenoxy)methyl)ethyl Hydrogen Succinate.
35. 4-(1-(dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-yloxy)-4-oxobutanoic Acid
36. 4-((1-(dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-yl)oxy)-4-oxobutanoic Acid
37. 4-(1-(2-(3-methoxyphenethyl)phenoxy)-3-(dimethylamino)propan-2-yloxy)-4-oxobutanoic Acid Sarpogrelate
38. 4-[1-dimethylamino-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic Acid
39. Butanedioic Acid, Mono(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl) Ester
40. Butanedioic Acid,1-[2-(dimethylamino)-1-[[2-[2-(3-methoxyphenyl)ethyl]phenoxy]methyl]ethyl]ester
41. Succinic Acid Mono-(2-dimethylamino-1-{2-[2-(3-methoxy-phenyl)-ethyl]-phenoxymethyl}-ethyl) Ester; Hydrochloride
| Molecular Weight | 429.5 g/mol |
|---|---|
| Molecular Formula | C24H31NO6 |
| XLogP3 | 1.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 14 |
| Exact Mass | 429.21513771 g/mol |
| Monoisotopic Mass | 429.21513771 g/mol |
| Topological Polar Surface Area | 85.3 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 540 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Fibrinolytic Agents
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Sarpogrelate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sarpogrelate, including repackagers and relabelers. The FDA regulates Sarpogrelate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sarpogrelate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sarpogrelate supplier is an individual or a company that provides Sarpogrelate active pharmaceutical ingredient (API) or Sarpogrelate finished formulations upon request. The Sarpogrelate suppliers may include Sarpogrelate API manufacturers, exporters, distributors and traders.
Sarpogrelate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sarpogrelate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sarpogrelate GMP manufacturer or Sarpogrelate GMP API supplier for your needs.
A Sarpogrelate CoA (Certificate of Analysis) is a formal document that attests to Sarpogrelate's compliance with Sarpogrelate specifications and serves as a tool for batch-level quality control.
Sarpogrelate CoA mostly includes findings from lab analyses of a specific batch. For each Sarpogrelate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sarpogrelate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sarpogrelate EP), Sarpogrelate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sarpogrelate USP).
LOOKING FOR A SUPPLIER?
